Trial-level factors affecting accrual and completion of oncology clinical trials: A systematic review
Background: Cancer is the second-leading cause of death in the United States. Clinical trials translate basic science discoveries into treatments needed by cancer patients. Inadequate accrual of trial participants is one of the most significant barriers to the completion of oncology clinical trials....
Guardado en:
Autores principales: | Cherie L. Hauck, Teresa J. Kelechi, Kathleen B. Cartmell, Martina Mueller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f41cc4ebcfb94631a01491f5ddab614d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Health literacy and informed consent for clinical trials: a systematic review and implications for nurses
por: Burks AC, et al.
Publicado: (2019) -
PLoS clinical trials
Publicado: (2006) -
Applied clinical trials
Publicado: (1992) -
Contemporary clinical trials
Publicado: (2005) -
The Impact of Earnings Management on the Predictive Ability of Accruals in Listed Companies in Tehran Stock Exchange (Implications for Earnings Quality)
Publicado: (2013)